Lab
Physicians Group Laboratories, LLC
Physicians Group Laboratories, LLC was paid $208.13M by Medicaid between Jan 2018 and Dec 2024, across 84 billing codes. Its largest line is 0225U, — 20% of everything it billed.
33Billing provider infoPHYSICIANS GROUP LABORATORIES, LLC
HOUMA, LA 70360
HOUMA, LA 70360
33aNPI1760897755assigned 06/27/2014
33bProvider typeClinical Medical Laboratory
28Total paid$208.13M
24GClaims4,619,179
24DCodes billed84
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Louisiana
Rank by total paid#1 of 66
Median peer was paid$253K
This provider vs. median824×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 83,516 | $4.95M | |
| 2019 | 238,249 | $13.23M | |
| 2020 | 843,112 | $43.58M | |
| 2021 | 987,574 | $51.47M | |
| 2022 | 900,383 | $44.91M | |
| 2023 | 711,189 | $25.37M | |
| 2024incomplete | 855,156 | $24.63M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0225U | 20% | 141,896 | 121,436 | $42.43M | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 19% | 156,087 | 128,372 | $39.02M |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 13% | 532,969 | 315,884 | $27.37M |
| 87150 | 5.9% | 61,200 | 49,832 | $12.35M | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 3.9% | 341,466 | 286,053 | $8.19M |
| 87481 | 3.9% | 338,759 | 275,414 | $8.09M | |
| 87640 | 3.8% | 330,653 | 276,691 | $7.91M | |
| 87653 | 3.8% | 331,509 | 275,443 | $7.89M | |
| 87541 | 3.4% | 293,214 | 249,450 | $7.00M | |
| 87561 | 3.2% | 265,514 | 227,608 | $6.65M | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 3.0% | 96,545 | 85,159 | $6.24M |
| 87507 | 2.9% | 20,779 | 18,436 | $5.94M |
72 more codes
| 87581 | 2.3% | 196,866 | $4.74M | |
| 87486 | 2.3% | 196,888 | $4.74M | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.1% | 31,672 | $2.39M |
| 87529 | <1% | 37,196 | $1.34M | |
| 87500 | <1% | 57,927 | $1.21M | |
| 87496 | <1% | 44,374 | $1.03M | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 36,569 | $877K |
| 87532 | <1% | 36,568 | $864K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 37,288 | $861K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 36,586 | $846K |
| 87625 | <1% | 59,337 | $805K | |
| 87631 | <1% | 11,231 | $779K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 41,752 | $681K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 19,669 | $597K |
| 87511 | <1% | 39,119 | $556K | |
| 80050 | General health panel | <1% | 24,599 | $480K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 30,485 | $435K |
| 84403 | <1% | 23,070 | $398K | |
| 82627 | <1% | 24,675 | $366K | |
| 84270 | <1% | 24,911 | $361K | |
| 82607 | <1% | 27,875 | $279K | |
| 83003 | <1% | 24,672 | $275K | |
| 82533 | <1% | 24,919 | $272K | |
| 82670 | <1% | 14,440 | $268K | |
| 82746 | <1% | 27,390 | $268K | |
| 80061 | Lipid panel | <1% | 30,197 | $212K |
| 84481 | <1% | 27,576 | $202K | |
| 83525 | <1% | 27,268 | $199K | |
| 84144 | <1% | 14,393 | $195K | |
| 87498 | <1% | 7,089 | $192K | |
| 84146 | <1% | 14,375 | $185K | |
| 82728 | <1% | 28,351 | $165K | |
| 83002 | <1% | 12,877 | $159K | |
| 84466 | <1% | 25,850 | $139K | |
| 83735 | <1% | 27,684 | $124K | |
| 84439 | <1% | 28,420 | $119K | |
| 83001 | <1% | 9,408 | $117K | |
| 82150 | <1% | 25,244 | $109K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 30,795 | $109K |
| 87563 | <1% | 7,333 | $99K | |
| 86431 | <1% | 25,722 | $97K | |
| 83615 | <1% | 23,681 | $96K | |
| 86140 | <1% | 25,413 | $88K | |
| 84100 | <1% | 27,647 | $87K | |
| 86759 | <1% | 6,530 | $84K | |
| 82977 | <1% | 25,805 | $80K | |
| 84550 | <1% | 25,536 | $77K | |
| 82248 | <1% | 25,422 | $71K | |
| 83540 | <1% | 28,784 | $70K | |
| 86723 | <1% | 6,528 | $52K | |
| 84154 | <1% | 3,846 | $48K | |
| 84153 | <1% | 4,244 | $45K | |
| 80053 | Comprehensive metabolic panel | <1% | 8,005 | $31K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 7,358 | $19K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 6,181 | $18K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 179 | $11K |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,395 | $9K |
| 84402 | <1% | 417 | $7K | |
| 83090 | <1% | 427 | $4K | |
| 87641 | <1% | 175 | $3K | |
| 87556 | <1% | 110 | $2K | |
| 87551 | <1% | 54 | $1K | |
| 87799 | <1% | 18 | $704.65 | |
| 84436 | <1% | 829 | $204.33 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 18 | $82.83 |
| 85651 | <1% | 25 | $80.10 | |
| 84480 | <1% | 744 | $12.76 | |
| 84479 | <1% | 743 | $9.24 | |
| 87503 | 0% | 27 | $0.00 | |
| 87451 | 0% | 20 | $0.00 | |
| 82172 | 0% | 744 | $0.00 | |
| 87634 | 0% | 23 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialYEATES, ANDREW (CEO)
| Provider | Location | Paid |
|---|---|---|
| PCLTX LLC | Houston, TX | $8.79M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.